Name | Number of supported studies | Average coverage | |
---|---|---|---|
cardiac muscle cell | 7 studies | 72% ± 26% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
heart | 6 studies | 30% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
heart | 100% | 26388.85 | 857 / 861 | 0% | 0 | 0 / 0 |
muscle | 96% | 2528.85 | 774 / 803 | 0% | 0 | 0 / 0 |
prostate | 5% | 31.14 | 13 / 245 | 4% | 0.27 | 21 / 502 |
adrenal gland | 4% | 15.92 | 10 / 258 | 3% | 0.35 | 6 / 230 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.06 | 1 / 45 |
liver | 0% | 0 | 0 / 226 | 2% | 0.06 | 9 / 406 |
thymus | 2% | 7.68 | 13 / 653 | 0% | 0.00 | 1 / 605 |
blood vessel | 2% | 79.88 | 24 / 1335 | 0% | 0 | 0 / 0 |
breast | 1% | 14.34 | 6 / 459 | 0% | 0.00 | 2 / 1118 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.03 | 5 / 430 |
brain | 1% | 6.08 | 23 / 2642 | 0% | 0.01 | 2 / 705 |
esophagus | 0% | 0.93 | 6 / 1445 | 1% | 0.01 | 1 / 183 |
uterus | 0% | 0 | 0 / 170 | 1% | 0.15 | 4 / 459 |
lung | 0% | 30.99 | 2 / 578 | 0% | 0.01 | 5 / 1155 |
stomach | 0% | 0 | 0 / 359 | 1% | 0.01 | 2 / 286 |
skin | 0% | 0.93 | 4 / 1809 | 0% | 0.00 | 1 / 472 |
pancreas | 0% | 0.96 | 1 / 328 | 0% | 0 | 0 / 178 |
adipose | 0% | 2.61 | 3 / 1204 | 0% | 0 | 0 / 0 |
intestine | 0% | 0.69 | 2 / 966 | 0% | 0 | 0 / 527 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0 | 0 / 901 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042761 | Biological process | very long-chain fatty acid biosynthetic process |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0016020 | Cellular component | membrane |
GO_0016491 | Molecular function | oxidoreductase activity |
GO_0016627 | Molecular function | oxidoreductase activity, acting on the CH-CH group of donors |
Gene name | TECRL |
Protein name | Trans-2,3-enoyl-CoA reductase like Trans-2,3-enoyl-CoA reductase-like (EC 1.3.1.-) (Steroid 5-alpha-reductase 2-like 2 protein) |
Synonyms | SRD5A2L2 |
Description | |
Accessions | ENST00000509536.1 H0Y9F0 ENST00000511997.1 E9PD39 D6RBZ3 ENST00000507440.5 Q5HYJ1 ENST00000381210.8 |